Back to results
US 2003/0147889 A1Published application
Antagonist of th-1 immunerresponse inducing cytokine for the treatment of autoimmune diseases
OwnerMichael Gerard Toveyinventor
Life of this patent
Estimating the term…
Abstract
Oromucosal administration of antagonists of cytokines associated with stimulation or enhancement of T helper 1 cell responses, preferably for example a Type 1-interferon antibody, is disclosed for inhibition of prevention of autoimmune diseases.
Claims12
Use of an antagonist of a cytokine which cytokine stimulates or enhances a Th 1 cell response for the manufacture of a composition for oromucosal administration of said antagonist to inhibit or treat a disease associated with action of said cytokine.
The use of an antibody as claimed in claim 5 wherein said antibody is a monoclonal anti-Type 1-IFN or anti-IFN-α antibody.
Dependencies are inferred from the claim text.